Key Takeaways
- • Irish SME venture capital funding collapsed 58% year-over-year in Q1 2026, dropping to €221.7 million from over €500 million in Q1 2025, according to the Irish Venture Capital Association VenturePulse survey.
- • International investors supplied 85% of Q1 capital raised, underscoring Irish SMEs' heavy dependence on overseas funding sources and exposure to global geopolitical headwinds, particularly the Iran War.
- • Life sciences dominated Irish VC allocation with 54% of total funding (€119.5 million), followed by fintech at 13% (€28 million) and software at 12% (€26.9 million), while AI represented only 2% of Irish VC deals despite commanding approximately 80% of the record $300 billion in global startup investment.
- • IVCA leadership expressed cautious optimism, framing the decline against an "exceptionally strong" Q1 2025 baseline and signaling that local policy initiatives could offset geopolitical uncertainty in subsequent quarters.
Summary
Irish technology SMEs experienced a sharp contraction in venture capital fundraising during the first quarter of 2026, with total VC investment plummeting 58% to €221.7 million compared to the same period in 2025, according to the Irish Venture Capital Association's VenturePulse survey published in association with William Fry. The decline reflects broader capital reallocation patterns globally, where artificial intelligence has become the dominant investment focus, capturing approximately 80% of the record $300 billion deployed into startups worldwide during Q1 2026.
The composition of Irish VC funding reveals a marked divergence from global investment trends. Life sciences emerged as the strongest sector, commanding 54% of total capital deployed (€119.5 million), with fintech and software following at 13% (€28 million) and 12% (€26.9 million) respectively. Despite AI's overwhelming dominance in global VC markets, Irish startups in this sector attracted only 2% of total domestic VC funding, highlighting the structural disconnect between Ireland's emerging technology ecosystem and the artificial intelligence investment boom concentrated in North American markets.
A critical vulnerability underpinning Irish SME fundraising dynamics is the sector's reliance on international capital sources. International investors accounted for 85% of Q1 2026 funding, intensifying Ireland's exposure to geopolitical risks and global investor sentiment shifts. Caroline Gaynor, IVCA chairperson, characterized the funding environment as "glass half full" territory, contextualizing the decline against the "exceptionally strong start to last year" when Irish firms raised over half a billion euros in the first quarter—a record at the time. Sarah-Jane Larkin, IVCA director general, acknowledged the uncertain impact of the Iran War on investor confidence in subsequent quarters but indicated that domestic policy initiatives could help mitigate geopolitical headwinds for early-stage Irish startups seeking capital throughout 2026.
The composition of Irish VC funding reveals a marked divergence from global investment trends. Life sciences emerged as the strongest sector, commanding 54% of total capital deployed (€119.5 million), with fintech and software following at 13% (€28 million) and 12% (€26.9 million) respectively. Despite AI's overwhelming dominance in global VC markets, Irish startups in this sector attracted only 2% of total domestic VC funding, highlighting the structural disconnect between Ireland's emerging technology ecosystem and the artificial intelligence investment boom concentrated in North American markets.
A critical vulnerability underpinning Irish SME fundraising dynamics is the sector's reliance on international capital sources. International investors accounted for 85% of Q1 2026 funding, intensifying Ireland's exposure to geopolitical risks and global investor sentiment shifts. Caroline Gaynor, IVCA chairperson, characterized the funding environment as "glass half full" territory, contextualizing the decline against the "exceptionally strong start to last year" when Irish firms raised over half a billion euros in the first quarter—a record at the time. Sarah-Jane Larkin, IVCA director general, acknowledged the uncertain impact of the Iran War on investor confidence in subsequent quarters but indicated that domestic policy initiatives could help mitigate geopolitical headwinds for early-stage Irish startups seeking capital throughout 2026.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.